Search research articles
Contact Us
Filters
Showing results (21-30 of 44) with videos related to
Page
of 5
Sort By:
The Journal of Clinical Endocrinology and Metabolism
|
June 6, 2003
Diurnal and ultradian dynamics of serum adiponectin in healthy men: comparison with leptin, circulating soluble leptin receptor, and cortisol patterns
Alina Gavrila, C-K Peng, Jean L Chan, et al.
The Journal of Clinical Endocrinology and Metabolism
|
October 15, 2003
Serum adiponectin levels are inversely associated with overall and central fat distribution but are not directly regulated by acute fasting or leptin administration in humans: cross-sectional and interventional studies
Alina Gavrila, Jean L Chan, Nikos Yiannakouris, et al.
Alimentary Pharmacology & Therapeutics
|
November 16, 2018
Randomised clinical trial: emricasan versus placebo significantly decreases ALT and caspase 3/7 activation in subjects with non-alcoholic fatty liver disease
Mitchell Shiffman, Bradley Freilich, Raj Vuppalanchi, et al.
The Journal of Clinical Endocrinology and Metabolism
|
October 15, 2003
Circulating resistin levels are not associated with obesity or insulin resistance in humans and are not regulated by fasting or leptin administration: cross-sectional and interventional studies in normal, insulin-resistant, and diabetic subjects
Jennifer H Lee, Jean L Chan, Nikos Yiannakouris, et al.
Clinical Endocrinology
|
November 22, 2015
Immunogenicity associated with metreleptin treatment in patients with obesity or lipodystrophy
Jean L Chan, Joy Koda, Joseph S Heilig, et al.
The New England Journal of Medicine
|
September 3, 2004
Recombinant human leptin in women with hypothalamic amenorrhea
Corrine K Welt, Jean L Chan, John Bullen, et al.
The Journal of Clinical Endocrinology and Metabolism
|
December 23, 2004
Recombinant methionyl human leptin administration activates signal transducer and activator of transcription 3 signaling in peripheral blood mononuclear cells in vivo and regulates soluble tumor necrosis factor-alpha receptor levels in humans with relative leptin deficiency
Jean L Chan, Stergios J Moschos, John Bullen, et al.
The Journal of Clinical Endocrinology and Metabolism
|
June 16, 2005
Circulating resistin levels are not associated with fat redistribution, insulin resistance, or metabolic profile in patients with the highly active antiretroviral therapy-induced metabolic syndrome
Diana Barb, Sanjivini G Wadhwa, Juergen Kratzsch, et al.
Clinical Endocrinology
|
March 31, 2004
Elevated leptin fragments in renal failure correlate with BMI and haematopoiesis and are normalized by haemodialysis
Dimitrios N Stamatiadis, Jean L Chan, Rebecca Cogswell, et al.
Metabolism: Clinical and Experimental
|
April 21, 2009
Effect of valsartan on left ventricular anatomy and systolic function and aortic elasticity
Lalita Khaodhiar, Aoife M Brennan, Christina Lima, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 44) with videos related to
Sort By:
Page
of 5
The Journal of Clinical Endocrinology and Metabolism
|
June 6, 2003
Diurnal and ultradian dynamics of serum adiponectin in healthy men: comparison with leptin, circulating soluble leptin receptor, and cortisol patterns
Alina Gavrila, C-K Peng, Jean L Chan, et al.
The Journal of Clinical Endocrinology and Metabolism
|
October 15, 2003
Serum adiponectin levels are inversely associated with overall and central fat distribution but are not directly regulated by acute fasting or leptin administration in humans: cross-sectional and interventional studies
Alina Gavrila, Jean L Chan, Nikos Yiannakouris, et al.
Alimentary Pharmacology & Therapeutics
|
November 16, 2018
Randomised clinical trial: emricasan versus placebo significantly decreases ALT and caspase 3/7 activation in subjects with non-alcoholic fatty liver disease
Mitchell Shiffman, Bradley Freilich, Raj Vuppalanchi, et al.
The Journal of Clinical Endocrinology and Metabolism
|
October 15, 2003
Circulating resistin levels are not associated with obesity or insulin resistance in humans and are not regulated by fasting or leptin administration: cross-sectional and interventional studies in normal, insulin-resistant, and diabetic subjects
Jennifer H Lee, Jean L Chan, Nikos Yiannakouris, et al.
Clinical Endocrinology
|
November 22, 2015
Immunogenicity associated with metreleptin treatment in patients with obesity or lipodystrophy
Jean L Chan, Joy Koda, Joseph S Heilig, et al.
The New England Journal of Medicine
|
September 3, 2004
Recombinant human leptin in women with hypothalamic amenorrhea
Corrine K Welt, Jean L Chan, John Bullen, et al.
The Journal of Clinical Endocrinology and Metabolism
|
December 23, 2004
Recombinant methionyl human leptin administration activates signal transducer and activator of transcription 3 signaling in peripheral blood mononuclear cells in vivo and regulates soluble tumor necrosis factor-alpha receptor levels in humans with relative leptin deficiency
Jean L Chan, Stergios J Moschos, John Bullen, et al.
The Journal of Clinical Endocrinology and Metabolism
|
June 16, 2005
Circulating resistin levels are not associated with fat redistribution, insulin resistance, or metabolic profile in patients with the highly active antiretroviral therapy-induced metabolic syndrome
Diana Barb, Sanjivini G Wadhwa, Juergen Kratzsch, et al.
Clinical Endocrinology
|
March 31, 2004
Elevated leptin fragments in renal failure correlate with BMI and haematopoiesis and are normalized by haemodialysis
Dimitrios N Stamatiadis, Jean L Chan, Rebecca Cogswell, et al.
Metabolism: Clinical and Experimental
|
April 21, 2009
Effect of valsartan on left ventricular anatomy and systolic function and aortic elasticity
Lalita Khaodhiar, Aoife M Brennan, Christina Lima, et al.
Page
of 5